Boner G, Wainer E, Rosenfeld J B
Clin Pharmacol Ther. 1982 Oct;32(4):423-7. doi: 10.1038/clpt.1982.183.
Effects of intravenous and long-term oral dosing with pindolol on renal function were examined in eight hypertensive patients with reduced renal function. (Inulin clearance ranged from 40.5 to 84.5 ml/min/1.73 m2.) Intravenous pindolol resulted in decreased mean heart rate (74.3 to 67 bpm) and decreased mean inulin clearance (66 to 60.5 ml/min/1.73 m2.) Blood pressure and renal plasma flow did not change significantly. Long-term oral pindolol depressed blood pressure and heart rate, but mean inulin clearance was unchanged and renal blood flow and plasma volume increased. A second intravenous pindolol dose, given while the patients were receiving oral doses, resulted in nonsignificant decreases in glomerular filtration rate and renal plasma flow, but no change in blood pressure and heart rate. We conclude that prolonged pindolol dosing in patients with reduced renal function had no effect on renal function. When the drug was given intravenously there were small decreases in glomerular filtration rate and renal plasma flow.
在8名肾功能减退的高血压患者中,研究了静脉注射及长期口服吲哚洛尔对肾功能的影响。(菊粉清除率范围为40.5至84.5 ml/min/1.73 m²)静脉注射吲哚洛尔导致平均心率降低(从74.3降至67次/分钟),平均菊粉清除率降低(从66降至60.5 ml/min/1.73 m²)。血压和肾血浆流量无显著变化。长期口服吲哚洛尔可降低血压和心率,但平均菊粉清除率未改变,肾血流量和血浆量增加。在患者接受口服剂量时给予第二次静脉注射吲哚洛尔,导致肾小球滤过率和肾血浆流量出现非显著下降,但血压和心率无变化。我们得出结论,在肾功能减退的患者中长时间给予吲哚洛尔对肾功能无影响。静脉给药时,肾小球滤过率和肾血浆流量有小幅下降。